Delivery Order SPE2DB20D1109-SPE2DB23FN48A
- Not listed
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $8,916.79 and an ultimate completion date of January 13, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.85, is a firm fixed-price delivery order with a completion date of July 26, 2022. The contract was awarded on July 25, 2022, and does not have a set-aside designation, indicating...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,348.88 and an ultimate completion date of February 1, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. The contract has a ceiling value of $60,160.90 and an ultimate...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The $13,522.97 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2023, with a completion date of December 7, 2023. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
- The federal contract award is for the delivery of Lidocaine 5% Patches, with a contract value of $8,341.71 and a completion date of June 4, 2024. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, with a ceiling value of $5,842.74, has an ultimate completion date of July 25, 2023. It is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Firm Fixed Price Delivery Order valued at $1,021.06. The contract has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The $2,561.63 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $2,871.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN48ADelivery Order
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor, Amerisourcebergen Drug Corp, was awarded a Firm Fixed Price Delivery Order valued at $2,093.83 with a completion date of February 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award was made through full and open competition, with no set-aside designation. Amerisourcebergen's parent company is Cencora, Inc., also a major pharmaceutical distributor that supports federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/6/23 |